A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
Study Identifier
195263-006
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
40+ years
Protocol Summary
This study will evaluate the safety and efficacy of AGN-195263 compared to vehicle in patients with meibomian gland dysfunction (MGD) in the eyelids.
Study Locations
Location
Status
Location
Cornea Consultants of Arizona
Phoenix, Arizona, United States, 85032
Status
Not applicable
Location
University of Arkansas for Medical
Little Rock, Arkansas, United States, 72205
Status
Not applicable
Location
Sall Research Medical Center
Artesia, California, United States, 90701
Status
Not applicable
Location
Orange County Ophthalmology Medical Group, Inc.
Garden Grove, California, United States, 92843
Status
Not applicable
Location
Lugene Eye Institute
Glendale, California, United States, 91205
Status
Not applicable
Location
Lakeside Vision Center
Irvine, California, United States, 92604
Status
Not applicable
Showing {first} - {last} of {total} Results